Pearl River Capital, LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Pearl River Capital, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$39.62 - $69.97 $142,830 - $252,241	-3,605 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$58.09 - $82.51 $209,414 - $297,448	3,605 New	3,605 $239,000
Q3 2019 Nov 08, 2019	SELL	$26.26 - $34.86 $109,976 - $145,993	-4,188 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$17.43 - $28.82 $72,996 - $120,698	4,188 New	4,188 $111,000
Q1 2019 May 02, 2019	SELL	$12.05 - $20.18 $7,109 - $11,906	-590 Closed	0 $0

Q4 2018 Feb 08, 2019	BUY	$10.74 - $19.7 $6,336 - $11,623	590 New	590 $7,000

296

88.5M

905K

387K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.